Copyright
©The Author(s) 2022.
World J Clin Cases. Jan 7, 2022; 10(1): 155-165
Published online Jan 7, 2022. doi: 10.12998/wjcc.v10.i1.155
Published online Jan 7, 2022. doi: 10.12998/wjcc.v10.i1.155
Table 2 Classification of 46 focal hypermetabolic thyroid lesions as malignant or benign according to the type of primary cancer (n = 46)
| Primary cancer | Malignant | Benign | Total |
| Breast | 5 | 6 | 11 |
| Kidney | 1 | 0 | 1 |
| Colorectal | 2 | 3 | 5 |
| GIST | 0 | 1 | 1 |
| Lung | 8 | 8 | 16 |
| Stomach | 2 | 0 | 2 |
| Uterine cervix | 3 | 0 | 3 |
| Sarcoma | 1 | 0 | 1 |
| Urinary bladder | 1 | 0 | 1 |
| Salivary gland | 1 | 0 | 1 |
| Lymphoma | 1 | 2 | 3 |
| Bone | 1 | 0 | 1 |
| Total | 26 | 20 | 46 |
- Citation: Lee H, Chung YS, Lee JH, Lee KY, Hwang KH. Characterization of focal hypermetabolic thyroid incidentaloma: An analysis with F-18 fluorodeoxyglucose positron emission tomography/computed tomography parameters. World J Clin Cases 2022; 10(1): 155-165
- URL: https://www.wjgnet.com/2307-8960/full/v10/i1/155.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i1.155